Overview

A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro® ECM to Placebo in Patients With Venous Leg Ulcers

Status:
Withdrawn
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the efficacy and safety of VitroGro® combined with standard care in the treatment of Venous Leg Ulcers (VLUs) compared to Placebo with standard care over the course of the 8-week treatment phase.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Tissue Therapies Ltd.